<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.0 Transitional//EN">
<!-- saved from url=(0032)http://www.twu.edu/academics.asp -->
<!-- server code header start--><HTML><HEAD><TITLE>Longitudinal Research</TITLE>
<META http-equiv=Content-Type content="text/html; charset=iso-8859-1">
<STYLE type=text/css>A {
	COLOR: #882222; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'; TEXT-DECORATION: none
}
A:hover {
	COLOR: #882222; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamo
nd, 'Times New Roman'; TEXT-DECORATION: underline
}
BODY {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
H1 {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
H2 {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
H3 {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
H4 {
	COLOR: #000000; FONT-FAMILY: Verd
ana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
H5 {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
TD {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
INPUT {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
SELECT {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
OPTION {
	COLOR: #000000
; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
TEXTAREA {
	COLOR: #000000; FONT-FAMILY: Verdana,Palatino, Arial, Helvetica, Garamond, 'Times New Roman'
}
</STYLE>

<META content="Microsoft FrontPage 4.0" name=GENERATOR></HEAD>
<BODY bgColor=#ffffff leftMargin=0 topMargin=0 rightMargin=0 marginheight="0" 
marginwidth="0">
<TABLE cellSpacing=0 cellPadding=0 width="100%" bgColor=#ffffff border=0>
  <TBODY>
  <TR>
    <TD align=right width="100%" height=30>
      
<TABLE cellSpacing=0 cellPadding=0 width="100%" align=right 
      bgColor=#772233 border=0>
        <TBODY>
        <TR>
          <TD width=7 bgColor=#772233><IMG height=30 alt="" 
            src="images/blank.gif" width=7></TD>
          <TD vAlign=center align=left width="100%" bgColor=#772233><b><font style="font-size: 20pt; color: #ffffff">&#160;<br>
            &#160;Longitudinal Research<br>
            &#160;</font></b></TD>
          <TD vAlign=center noWrap align=left bgColor=#772233><a
 style="font-size: 8pt; color: #ffffff">&#160;</a><BR><a style="font-size: 8pt; color: #ffffff">FS
            6413</a><BR></TD>
          <TD align=right>
            &nbsp;</TD></TR></TBODY></TABLE></TD></TR>
  <TR>
    <TD width="100%" height=19>
      <TABLE height=19 cellSpacing=0 cellPadding=0 width="100%" border=0>
        <TBODY>
        <TR>
          <TD vAlign=center align=middle width=150 bgColor=#772233>
            <p align="center"><a style="font-size: 8pt; color: #ffffff">&#160;</a
></p>
          </TD>
          <TD vAlign=top align=left width=15><IMG height=19 alt="" 
            src="images/vt-ur.gif" width=15></TD>
          <TD vAlign=top width="100%">
            <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
              <TBODY>
              <TR>
                <TD bgColor=#772233 height=8><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#591a26 height=1><IMG
 height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#3c111a height=1><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#1e080d height=1><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#000000 height=1><IMG height=1 alt="" 

                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#404040 height=1><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#808080 height=1><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#bfbfbf height=1><IMG height=1 alt="" 
               
   src="images/blank.gif" 
              width=1></TD></TR>
              <TR>
                <TD bgColor=#ffffff height=4><IMG height=1 alt="" 
                  src="images/blank.gif" 
              width=1></TD></TR></TBODY></TABLE></TD></TR>
        <TR>
          <TD vAlign=center noWrap align=middle width=150 bgColor=#772233>
            <p align="center"><a style="font-size: 8pt; color: #ffffff">&#160;&#160;</a></p>
 </TD>
          <TD vAlign=top align=left width=15 
          background
="images/vt-ur-2.gif" 
          bgColor=#772233 height="100%"><IMG height="100%" alt="" 
            src="images/vt-ur-2.gif" width=15></TD>
          <TD vAlign=top width="100%"><a style="font-size: 8pt; color: #ffffff">&#160;</a><IMG height=1 alt="" 
            src="images/blank.gif" 
        width=1></TD></TR></TBODY></TABLE></TD></TR>
  <TR>
    <TD>
      <TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>
        <TBODY>
        <TR>
          <TD vAlign=top align=left width=160 hei
ght="100%">
            <TABLE cellSpacing=0 cellPadding=0 width=160 border=0>
              <TBODY>
              <TR>
                <TD width=7 bgColor=#772233><IMG alt="" 
                  src="images/blank.gif" width=7></TD>
                <TD vAlign=top align=left width=153><!--- Buttons --->
                  <TABLE cellSpacing=0 cellPadding=0 width=153 border=0 
                  valign="top">
                    <TBODY>
                    <TR bgColor=#772233>
                      <T
D vAlign=top align=right width=143 colSpan=2>
                        <p align="center"><a style="font-size: 9pt; color: #ffffff" href="http://www.twu.edu/cope/famsci/">Department
            of<br>
            Family Sciences</a></TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif">&nbsp;</TD></TR>
                    <TR bgColor=#772233>
                      <TD vAlign=top align=right width=143 colSpan=2>
                        <p align="center"><a styl
e="font-size: 8pt; color: #ffffff">&#160;</a></TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif">&nbsp;</TD></TR>
                    <TR bgColor=#772233>
                      <TD vAlign=top align=right width=143 colSpan=2>
                        <p align="center"><a style="font-size: 9pt; color: #ffffff" href="http://www.twu.edu/cope/">College
                        of Professional Education</a></TD>
                      <TD width=10 
               
       background="images/vt-b-r-1.gif">&nbsp;</TD></TR>
                    <TR bgColor=#772233>
                      <TD vAlign=top align=right width=143 colSpan=2>
                        <p align="center"><a style="font-size: 8pt; color: #ffffff">&#160;</a></TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif">&nbsp;</TD></TR>
                    <TR bgColor=#772233>
                      <TD vAlign=top align=right width=143 colSpan=2>
                 
       <p align="center"><a style="FONT-SIZE: 9pt; COLOR: #ffffff" href="http://www.twu.edu/default.asp">TWU Home</a> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif">&nbsp;</TD></TR>
                    <TR bgColor=#772233>
                      <TD vAlign=top align=right width=143 colSpan=2><a href="http://www.twu.edu/default.asp"><IMG height=57 
                        alt=T.W.U. 
                        src="images/twu.jpg" 
                        
width=139 border=0></a></TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif"><IMG 
                        alt="" 
                        src="images/vt-b-r-1.gif" 
                        width=10></TD></TR>
                    <TR>
                      <TD width=9 bgColor=#772233><IMG alt="" 
                        src="images/blank.gif" 
                        width=9></TD>
                      <TD align=left width=134 bgColor=#772233><a style="fo
nt-size: 8pt; color: #ffffff">&#160;</a> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233><IMG alt="" 
                        src="images/vt-b-r-1.gif" 
                        width=10></TD></TR>
                    <TR>
                      <TD vAlign=bottom><IMG height=8 alt="" 
                        src="images/vt-b-ll-4.gif" 
                        width=9></TD>
                      <TD vAlign=bottom 

                      background="images/vt-b-b-1.gif"><IMG 
                        height=8 alt="" 
                        src="images/vt-b-b-1.gif" 
                        width=134></TD>
                      <TD vAlign=bottom><IMG height=8 alt="" 
                        src="images/vt-b-lr-1.gif" 
                        width=10></TD></TR>
                    <TR>
                      <TD vAlign=top colSpan=3>
                        <TABLE cellSpacing=0 cellPadding=0 width=153 border=0
>
                          <TBODY>
                          <TR>
                            <TD vAlign=top><IMG height=9 alt="" 
                              src="images/vt-b-ul-2.gif" 
                              width=9></TD>
                            <TD vAlign=top bgColor=#ffffff>
                              <TABLE cellSpacing=0 cellPadding=0 border=0>
                                <TBODY>
                                <TR>
                                <TD vAlign=top 
       
                         background="images/vt-b-t-2.gif"><IMG 
                                height=4 alt="" 
                                src="images/vt-b-t-2.gif" 
                                width=134></TD></TR></TBODY></TABLE>
                            <TD vAlign=top><IMG height=9 alt="" 
                              src="images/vt-b-ur-2.gif" 
                              width=10></TD></TR>
                          <TR>
                            <TD 
                         
   background="images/vt-b-l-2.gif" 
                            bgColor=#ffffff><IMG height="100%" alt="" 
                              src="images/vt-b-l-2.gif" 
                              width=9></TD>
                            <TD vAlign=center align=left width=134 
                            bgColor=#ffffff><b><font style="font-size: 9pt; color: #000000" color="#000000" size="2">HRT</font></b> </TD>
                            <TD 
                            background="images/vt-b-r-2.g
if" 
                            bgColor=#ffffff><IMG height="100%" alt="" 
                              src="images/vt-b-r-2.gif" 
                              width=10></TD></TR>
                          <TR>
                            <TD vAlign=bottom><IMG height=8 alt="" 
                              src="images/vt-b-ll-2.gif" 
                              width=9></TD>
                            <TD 
                            background="images/vt-b-b-2.gif"><IMG 
                  
            height=4 alt="" 
                              src="images/vt-b-b-2.gif" 
                              width=134></TD>
                            <TD vAlign=bottom><IMG height=8 alt="" 
                              src="images/vt-b-lr-2.gif" 
                              width=10></TD></TR></TBODY></TABLE></TD></TR>
                    <TR>
                      <TD vAlign=top width=9 height=9><IMG height=9 alt="" 
                        src="images/vt-b-ul-3.gif" 
                
        width=9></TD>
                      <TD width=134 
                      background="images/vt-b-t-1.gif" 
                      height=9><IMG height=9 alt="" 
                        src="images/vt-b-t-1.gif" 
                        width=134></TD>
                      <TD vAlign=top width=10 height=9><IMG height=9 alt="" 
                        src="images/vt-b-ur-1.gif" 
                        width=10></TD></TR>
                    <TR>
                      <TD width=9 bgColor=#77
2233><IMG alt="" 
                        src="images/blank.gif" 
                        width=9></TD>
                      <TD align=left width=134 bgColor=#772233><A 
                        href="a.htm"><font style="font-size: 9pt; color: #ffffff" color="#ffffff" size="2">Contents</font></A> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233><IMG alt="" 
                        src="images/vt-b-r-1.gif" 
     
                   width=10></TD></TR>
                    <TR>
                      <TD width=9 bgColor=#772233>&nbsp;</TD>
                      <TD align=left width=134 bgColor=#772233><a style="font-size: 8pt; color: #ffffff">&#160;</a> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233>&nbsp;</TD></TR>
                    <TR>
                      <TD width=9 bgColor=#772233><IMG alt="" 
                    
    src="images/blank.gif" 
                        width=9></TD>
                      <TD align=left width=134 bgColor=#772233><A 
                        href="b.htm"><font style="font-size: 9pt; color: #ffffff" color="#ffffff" size="2">List of Authors</font></A> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233><IMG alt="" 
                        src="images/vt-b-r-1.gif" 
                        width=10></TD
></TR>
                    <TR>
                      <TD width=9 bgColor=#772233>&nbsp;</TD>
                      <TD align=left width=134 bgColor=#772233><a style="font-size: 8pt; color: #ffffff">&#160;</a> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233>&nbsp;</TD></TR>
                    <TR>
                      <TD width=9 bgColor=#772233><IMG alt="" 
                        src="images/blank.gif" 
   
                     width=9></TD>
                      <TD align=left width=134 bgColor=#772233><A 
                        href="c.htm"><font style="font-size: 9pt; color: #ffffff" color="#ffffff" size="2">About
                        this site</font></A> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233><IMG alt="" 
                        src="images/vt-b-r-1.gif" 
                        width=10></TD></TR>

                    <TR>
                      <TD width=9 bgColor=#772233>&nbsp;</TD>
                      <TD align=left width=134 bgColor=#772233><a style="font-size: 8pt; color: #ffffff">&#160;</a> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233>&nbsp;</TD></TR>
                    <TR>
                      <TD width=9 bgColor=#772233><IMG alt="" 
                        src="images/blank.gif" 
          
              width=9></TD>
                      <TD align=left width=134 bgColor=#772233><A 
                        href="d.htm"><font style="font-size: 9pt; color: #ffffff" color="#ffffff" size="2">About FS 6413</font></A> </TD>
                      <TD width=10 
                      background="images/vt-b-r-1.gif" 
                      bgColor=#772233><IMG alt="" 
                        src="images/vt-b-r-1.gif" 
                        width=10></TD></TR></TBODY></TABLE></TD></TR>
       
       <TR>
                <TD colSpan=2><IMG height=8 alt="" 
                  src="images/vt-b.gif" 
              width=161></TD></TR>
              <TR>
                <TD><IMG alt="" 
                  src="images/blank.gif" width=7></TD>
                <TD>
                  <TABLE cellSpacing=0 cellPadding=4 border=0>
                    <TBODY>
                    <TR>
                      <TD width=153><!*********** BEGIN BONUS CONTENT **************><a style="font-size: 8pt; color:
 #ffffff">&#160;</a> <BR><A 
                        href="http://www.twu.edu/default.asp"><IMG height=136 
                        alt="Texas Woman's University Seal" 
                        src="images/twuseal.jpg" 
                        width=135 border=0> </A></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></TD>
          <TD vAlign=top width="100%">
            <TABLE cellPadding=4 width="100%" border=0>
              <TBODY>
              <TR>
                <TD align=left></TD></TR>

              <TR>
                <TD width="100%">
                  <!-- server code footer start--></TD></TR>
              <TR>
                <TD width="100%">
                  <TABLE cellSpacing=8 cellPadding=8 width="100%" border=0>
                    <TBODY>
                    <TR>
                      <TD width="5%">&nbsp;</TD>
                      <TD width="95%" colSpan=2><b><FONT size=2>Barbara Mathews
                        Blanton,</FONT></b><font size="2"><b> MSN, RN, CARN<
/b></font></TD></TR>
                    <TR>
                      <TD width="5%">&nbsp;&nbsp;</TD>
                      <TD width="95%" colSpan=2><a><b>The Risks and Benefits of Long Term Hormone Replacement
                        Therapy</b></a></TD></TR>
                    <TR>
                      <TD width="5%">&nbsp;</TD>
                      <TD width="5%">&nbsp;</TD>
                      <TD vAlign=top width="90%"><font size="2"><b>A Research
                        Review</b></font>

                        <p><font size="2">The National Institutes of Health conducted a large randomized clinical trial on the risks and benefits of hormone replacement therapy (Woman's Group for the Women's Health Initiative Investigators, 2002). The research design is a longitudinal and observational clinical trial of the two most used HRT drugs, Premarin (estrogen alone made with pregnant mare’s urine) and Prempro (a combination of Premarin and Progestin, a synthetic progesterone) with a control group.
&nbsp;</font></p>
                        <p><font size="2">	Many volunteers responded to the study recruitment. From these, researchers randomly selected 16,808 participants from those who agreed to sign the consent form to take one of the two drugs.  These participants were assigned to the two hormone groups.  The control group came from women who were not willing to take either of the two drugs.  This nationwide randomized study conducted in 40 centers in the United States.&nbsp;</font></p>
           
             <p><font size="2">	Accumulating research had led these investigators to hypothesize positive outcomes for the participants in the following areas: heart disease, hip fractures, and colon cancer.  Because of previous research, there was also some suspicion that breast cancer rates might be higher, which is a negative outcome.  No investigators had done longitudinal research on HRT and the long-term effects of continual female hormone ingestion after menopause.   Six million American menopausal w
omen used the drug at the time of the study (Michalowiski and Nelson, 2002).   Another 8 million women used
                        Premarin.</font></p>
                        <p><font size="2">During the study, data were to be collected at selected intervals over eight years.  Elder (2002) stated that longitudinal research studies changing times and lives.  In this biological longitudinal research, changing physiology and potential damaging side effects were clearly identified.   Cross-sectional researc
h of one or two factors in the past has been less powerful in predicting dangerous outcomes with female hormones.</font></p>
                        <p><font size="2">Triggers were put in place by the Data and Safety Monitoring Board to notify researchers if the risk and benefit findings were negative.  This triggering happened at five years in the Prempro group when statistically significant negative findings occurred and that portion of the study was immediately suspended.	Watts (2002) found a 26% increa
se in the breast cancer risk, 41% increase in strokes, 29% increase in heart attacks, and 100% increase in venous thromboembolic events in women taking the Prempro.  Interestingly, there were no triggers for the cohort taking the estrogen alone.  That part of the study continues. The researchers are also conducting retrospective analysis for new variables.</font></p>
                        <p><font size="2">This study on the long-term impact of HRT on women was long overdue.  The impact on women’s health 
choices is enormous.  This study will probably produce other important information for women’s health.  Already it is changing the whole culture of whether or not women should take some forms of HRT for anything but acute menopausal symptoms.  Experts from within the study and other researchers are saying that for every 10,000 women treated for five years with Prempro, there are 100 undesirable events compared to untreated women (Wilson, 2002).  This is not a huge number but it is more than would be expecte
d if a woman were not taking
                        HRT.</font></p>
                        <p><font size="2">The experts further recommend that because of the power of this study, it is just not wise to use HRT for anything but severe menopausal symptoms and then only over the short term.  These experts recommend that everyone stop taking the Prempro version Estrogen and Progestin HRT because the risks outweigh the benefits.&nbsp;</font></p>
                        <p><font size="2">	Both women and the
ir physicians continue to be rocked by the findings in this study.  Many incorrect assumptions by physicians have been exposed.  This has highlighted a major weakness of the hallowed medical model.  In addition, the 6 million users of Prempro now must see if they were dramatically harmed by this drug over the long term.  Extrapolating from the rate given of 100 harmful outcomes per 10,000 patients taking the drug, there is a life long possibility of 60,000 bad outcomes directly related to the hormone combin
ation for six million women.</font></p>
                        <p><font size="2">Clearly, there is a major cultural and political phenomenon happening when millions of women are taking significant drugs that may be dangerous to their health with no longitudinal research to support the drugs’ efficacy or safety profile over time.  The history of biomedical research is fraught with problems with women participants (Stanford, 1995).  Medication testing was often not done on women because it was feared that a
 woman could become pregnant and have her fetus harmed by the medication. Unfortunately, this rationale was employed even when potential women participants were at no risk of becoming pregnant due to a hysterectomy or menopause.&nbsp;</font></p>
                        <p><font size="2">	The lack of research on women seemed to be institutionalized in the culture of the major funders of medical research in this country because researchers believed there were too many variables in using women as participants
.  One could also make a case for the fact that medicine and research was male dominated.  Research inquiries about women seemed to be much lower on researchers’ and funders’ radar screens until they were forced to address the issue.  Change in this area may also have been influenced by the fact that women were entering both fields in larger numbers.&nbsp;</font></p>
                        <p><font size="2">	After much controversy, the National Institutes of Health mandated that women must be included in 
all appropriate research they would fund in 1994(Government Accounting Office, May 2002). In addition, the NIH formed the Woman’s Health Initiative to promote research on neglected women’s health issues.  The Woman’s Health Initiative within NIH is responsible for this and several other ground breaking studies. From the time of the mandate, women have been included in much of the research designs of other NIH departments.&nbsp;</font></p>
                        <p><font size="2">	Researchers are discoveri
ng that women and men frequently respond differently to drugs.  What works in a woman might not work as well in a man. Conversely, what works in a man, might not work or be dose-appropriate in a man.  Most of the drugs approved by the Federal Drug Administration before the mandate and used by physicians even today, have never been tested on women. This longitudinal research has greatly reinforced that issue.</font></p>
                        <p><font size="2"><b>References</b></font></p>
                
        <p><font size="2">Elder, G. (2002). Historical times and lives:
                        A journey through time and space. In E. Phelps, F. Furstenberg,
                        &amp; A. Colby (Eds.), <i> Looking at lives</i> (pp. 194-195). New York: Russell Sage Foundation.&nbsp;</font></p>
                        <p><font size="2">Mickalowski, J., &amp; Nelson, N. (2002, August 30). Summary of the evidence of the risks and benefits of postmenopausal use of hormones. Retrieved March 4, 2003, from 
National Cancer Institute Web Site:
                        <a href="http://newscenter.cancer.gov/BenchMarks/archives/2002_08?related_print_html">http://newscenter.cancer.gov/BenchMarks/archives/2002_08?related_print_html</a>&nbsp;</font></p>
                        <p><font size="2">Stanford University. (Feb 10 1995). Women as subjects in research. Retrieved March 3,
                        2003, from Stanford University Web Site:
                        <a href="http://stanford.edu/dept/DoR/rph/7.2.ht
ml">http://stanford.edu/dept/DoR/rph/7.2.html</a></font></p>
                        <p><font size="2">United States Government Accounting Office. (May, 2000). Women's Health: NIH has increased its efforts to include women in research. Retrieved March 5, 2003, from United States Government Accounting Office Web Site:
                        <a href="http://gao.gov/new.items/he00096.pdf">http://gao.gov/new.items/he00096.pdf</a></font></p>
                        <p><font size="2">Watts, N. (2002). Lessons
 learned from the women's health initiative.
                        <i> Southern Medical Journal, 95</i>(9), 951-965.&nbsp;</font></p>
                        <p><font size="2">Wilson, N. (3003, August 1). Experts weigh in on hormone therapy. Retrieved March 4, 2003, from National Cancer Institute Web Site:
                        <a href="http://newscenter.cancer.gov/BenchMarks/archives/2002_07/feature_print.html">http://newscenter.cancer.gov/BenchMarks/archives/2002_07/feature_print.html</a></font></p
>
                        <p><font size="2">Woman's Group for the Women's Health Initiative Investigators (2002). Risks and benefits of Estrogen plus Progestin in healthy menopausal women.
                        <i> Journal of the American Medical Association, 288</i>(3), 321-333.</font></p>
                        <P><FONT size=1><b>© 2003 </b></FONT><font size="1"><b>Barbara Mathews Blanton, MSN, RN,
                        CARN</b></font> </P>
                      </TD></TR>
                    <
/TBODY></TABLE>
                </TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE></TD></TR></TBODY></TABLE><!-- server code footer end--></BODY></HTML>
                                                                                                                                                                                                                                                                                                                                                                   
